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Heritability and genetic and 
environmental correlations of heart 
rate variability and baroreceptor 
reflex sensitivity with ambulatory 
and beat-to-beat blood pressure
tengfei Man1, Harriëtte Riese2, Deepali Jaju3, M. Loretto Muñoz1, Mohammed o. Hassan4, 
said Al-Yahyaee5, Riad A. Bayoumi6, Anthony G. Comuzzie7, John s. Floras8, 
Arie M. van Roon9, Ilja M. Nolte  1, Sulayma Albarwani3 & Harold snieder1
This family study from Oman (n = 1231) explored the heritability and genetic and environmental 
correlations of heart rate variability (HRV) and baroreceptor reflex sensitivity (BRS) with ambulatory 
and beat-to-beat blood pressure (BP). Ambulatory BP was measured for 24 hours to calculate mean 
values for daytime and sleep separately. Time and frequency domain HRV indices, BRS, office beat-
to-beat BP, and heart rate (HR) were measured for 10 minutes at rest. SOLAR software was used to 
perform univariate and bivariate quantitative genetic analyses adjusting for age, age2, sex, their 
interactions and BMI. Heritability of SBP and DBP ranged from 16.8% to 40.4% for daytime, sleeping, 
24-hour and office beat-to-beat measurements. HR and BRS showed a heritability of 31.9% and 20.6%, 
respectively, and for HRV indices heritability ranged from 11.1% to 20.5%. All HRV measurements 
and BRS were found to be negatively correlated with BP, but phenotypic correlation coefficients were 
relatively weak; HR was positively correlated with BP. None of the genetic correlations were statistically 
significant while environmental factors explained most of the correlations for all HRV indices with BP. 
Our study found consistent but weak correlations among HRV, HR, BRS and ambulatory/office beat-to-
beat BP. However, environmental rather than genetic factors contributed most to those correlations.
Hypertension (HTN) is a progressive cardiovascular syndrome and is usually defined by the presence of a chronic 
elevation of systemic arterial pressure above a certain threshold value. Blood pressure (BP) serves as the underly-
ing biomarker that defines HTN and it is commonly used as key indicator to assess the disease severity combined 
with other CV risk factors1. Two common methods are typically used to measure BP at the upper arm for diagno-
sis of HTN: traditional BP measurement in the physician’s office and ambulatory BP measurement2.
Higher BP or HTN has been found to be associated with higher heart rate (HR) and lower heart rate varia-
bility (HRV) in cross-sectional3,4 and prospective studies5,6. HRV is the physiological phenomenon of variation 
in the time interval between heartbeats and is a quantitative marker of the autonomic modulation of sinus node 
discharge7. The baroreflex feedback loop is an important cardiovascular control mechanism for short-term BP 
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regulation as it registers and dampens fluctuations in BP through sympathetic and parasympathetic nervous 
system modulation of, especially, the HR. Baroreceptor reflex sensitivity (BRS) can be defined as the transfer 
function between BP and HR changes8. A reduction in BRS has been shown to lead to a reduced buffering of BP 
fluctuations9, which in time can potentially result in a higher absolute BP setpoint around which the BP level is 
regulated10.
Previous twin and family studies indicated that BP, HR, HRV and BRS are all heritable (genetic factors con-
tributing a substantial part of the variance in those traits). A systematic review and meta-regression of twin 
studies published recently reported that the mean (95% CI) heritabilities for systolic BP, diastolic BP and HR 
were 0.54 (0.48–0.60), 0.49 (0.42–0.56), and 0.61 (0.51–0.70), respectively11. A recent review on the genetics of 
autonomic nervous system activity summarized the results from previous twin studies with a sample size over 50 
twin pairs and reported heritability estimates between 25 and 70% for the different indices of HRV and between 
22 and 55% for BRS12.
Given that both BP and indices of autonomic nervous system activity (HRV, BRS) are heritable raises the ques-
tion whether the inverse associations between these variables identified in observational studies may partly be 
explained by shared genetic factors influencing both classes of phenotypes. This hypothesis has not been explored 
previously. Population based family study designs have the potential to facilitate the analysis of the effects of both 
genes and environment. We will, therefore, test this hypothesis with data from the Oman Family Study (OFS), an 
isolated population that is environmentally and genetically homogeneous13. In the OFS, ambulatory BP (daytime, 
sleeping, and 24-hour) and office beat-to-beat BP were collected together with laboratory assessments of a wide 
range of HRV indices, HR and BRS in a large number of participants.
Methods
Study Population. Five large, extended and highly consanguineous families (1231 subjects in total and 304, 
142, 225, 279 and 281 persons separately), each living in a separate village within a perimeter of 20 km around 
the City of Nizwa were selected. Interviewed people represented approximately 10–15% of the total number of 
individuals in these five pedigrees. They were 16–80 years old and all voluntarily took part in the study, appeared 
healthy, and had no clinical complaints as determined by a questionnaire. In these five pedigrees, first cousin mar-
riages represent >50% of all marriages. Polygamy is widely practiced with some men marrying up to 4 wives14. 
The study was approved by the Medical Research and Ethics Committee of Sultan Qaboos University. A written 
and signed or thumb-printed rubber-stamped informed consent was obtained from each subject or a parent and/
or legal guardian if subjects were under the age of 18 years.
Ambulatory BP Measurements. Ambulatory BP measurements were recorded during the course of a 
whole 24-hour day on a first home visit, using the auscultatory mode of the validated Schiller BR 102 ambulatory 
BP monitor (Baar, Switzerland). With the subject seated the appropriate size cuff was fixed to the non-dominant 
arm and three BP readings taken. During the same home visit three BP readings were also taken with a calibrated 
mercury sphygmomanometer on the dominant arm to confirm accuracy of the ambulatory BP measurements. 
Recordings were accepted and ambulatory BP recordings started when the average of both measurement methods 
did not differ by >5 mmHg. To reduce movement artefacts during ambulatory BP recordings, subjects were dis-
couraged from strenuous physical activity. The BP monitor was programmed to record BP every 30 minutes from 
07:30 to 21:30 and every 60 minutes from 21:30 to 09:30, for a total of 26 hours. The first 2 hours of monitoring 
were considered as an adaptation period and were not included in the calculation of BP means. Recordings were 
accepted when the rate of invalid measurements due to e.g. artefacts was <25% and when the recording lasted 
for at least 20 consecutive hours. Quality control of data output from the 24-hour monitor for SBP and DBP was 
performed by one technician, trained at identifying artefacts and outliers. The daytime and sleep periods were 
determined for each subject according to their actual waking and sleeping time as recorded in their diaries and 
confirmed by changes in BP. The average BP levels during the total 24 hours and during daytime and sleep periods 
were calculated15.
Beat-to-beat BP and HR/HRV measurement. After reporting to the field research center at 7.00 am and 
removing the BP monitor subjects were made to rest in supine position for 10 minutes on a comfortable bed, in 
a quiet office with a temperature between 24 and 26 °C. Measurements were acquired for the subsequent 10 min-
utes using the Task Force Monitor (CNS systems, Graz, Austria). The beat-to-beat BP was recorded using the 
vascular unloading technique whereby finger cuff readings were recorded, automatically counterchecked and cor-
rected every minute, by the oscillometric BP measurements recorded from the contralateral upper arm15. Subjects 
(n = 10) with more than 5% of their ECG signals not meeting our ECG signal criteria (i.e. NN-intervals between 
300 ms and 2000 ms and successive NN-interval ratios between 0.8 and 1.2) were excluded. Measurements (n = 3) 
that deviated by more than 4 standard deviations (SD) from the mean for a trait, were set to missing for the corre-
sponding trait. Subjects taking anti-hypertensives (n = 189) were not asked to stop medication, but the measured 
BP results were corrected (+15 mmHg for SBP and +10 mmHg for DBP) prior to analysis16,17.
Inter beat intervals (IBI, or RR-intervals) were obtained from lead II of a 6-lead ECG and used to calcu-
late average HR and HRV. Time domain HRV indices included the standard deviation of the normal-to-normal 
interval (SDNN) and the square root of the mean squared differences of successive normal-to-normal intervals 
(RMSSD). Frequency domain measures were high frequency (HF, 0.15–0.40 Hz; reflecting the strength of HR 
modulation by the parasympathetic system, i.e., the vagus nerve), low frequency (LF, 0.04–0.15 Hz; reflecting a 
mixture of sympathetic and parasympathetic activity) and very low frequency (VLF, 0.003–0.15 Hz; reflecting a 
host of factors, including not only the sympathetic nervous system, but also input from chemoreceptors, ther-
moreceptors, the renin-angiotensin system and others) and the sum of these frequency bands (HF + LF + VLF) 
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giving an estimate of the total power (TP, 0–0.4 Hz, reflecting the overall autonomic activity). All these are com-
monly used HRV indices7,18
BRS Calculation. BRS was calculated based on the computer identification of spontaneously occurring 
sequences of four or more beats in the time domain and slope of the regression line between SBP and RR inter-
val changes is taken as an index of the BRS. The sequence should have consecutive four or more beats showing 
an increase in SBP associated with prolongation of RR-interval (up-up events) or a fall in SBP with shortening 
RR-interval (down-down events). Since these sequences are spontaneous, only those with a consecutive 1 mmHg 
change in SBP and at least 1 ms change in R-R interval were included into the analysis. Consequently, there is a 
high proportion of missing data for the BRS based on up-up events (31.3%) and down-down events (28.4%). To 
optimize sample size based on all available data of up-up and/or down-down events we calculated a new average 
BRS variable [BRS = (BRS up-up + BRS down-down)/2] if both of them were available and used only BRS up-up 
or BRS down-down if either of them was missing. Distributional characteristics of the log-transformed BRS 
up-up (mean [SD] = 2.61 [0.69]) and log-transformed BRS down-down (mean [SD] = 2.62 [0.67]) variables were 
highly similar (distribution of log-transformed BRS up-up and down-down variables is shown in Supplemental 
Fig. 1).
statistical Analysis. Descriptive statistics were used to present the baseline characteristics of the study sam-
ple and Student’s t-tests were used to test for sex differences in the means. Prior to analysis, distributions of all 
variables were checked. To obtain better approximations of normal distributions of HR, HRV and BRS, measure-
ments were transformed by natural logarithm (distributions of these variables before and after log transformation 
are shown in Supplemental Fig. 2). SOLAR (v7.2.5), a standard software package for variance components and 
linkage analysis of family data was used to perform univariate and bivariate analyses19,20.






SOLAR uses a variance-component method to analyze family-based quantitative data by decomposing the 
overall phenotypic variance into genetic and environmental components using the observed covariance in the 
trait among family members (Φ is n*n matrix of kinship coefficients that structures σ2G i.e. the variance due to 
the additive genetic effects [σ2G]; and I is the identity matrix of order n). Each genetic and environmental variance 
component is accompanied by a structuring matrix that predicts the covariance among individuals associated 
to that component. The structuring matrix for σ2G is twice the kinship coefficient (2Φ) and for unmeasured, 
non-genetic factors (i.e. σ2E) it is the identity matrix I, this is shown in equation 1.




SOLAR estimates additive genetic or narrow sense heritability which is the proportion of the phenotypic 
variance (σ2P) attributed to additive genetic effects (σ2G) using equation 2. The h2 significance was determined 
by using a likelihood ratio test where the log-likelihood of the estimated model is compared to the nested model 
where σ2G is fixed to zero21.
r h r h e r e( ) ( ) (3)p BP G HRV BP E HRV
2 2 2 2= × × + × ×
In our study the bivariate quantitative genetic analyses were conducted to estimate the genetic and environ-
mental correlations of HRV, HR and BRS with BP. This is an extension of equation 1 where the phenotypic covar-
iance between two individuals for two traits is given by a 2*2 covariance matrix resulting in equation 3, where rG 
is the additive genetic correlation and rE is the environmental correlation between HRV and BP.
With the additive genetic correlation (rG) we measured the extent of common genetic effects on the two traits 
being analyzed (i.e. pleiotropy). To test for the significance of shared genetic effects (|rG| >0), rG was first esti-
mated and subsequently fixed to zero in a nested sub-model allowing for a comparison of the two models using a 
likelihood ratio test. Similarly to test for complete overlap of genetic effects (rG = 1), rG was fixed to one and com-
pared to the more general model in which it was freely estimated. If rG = 0, this means that two traits being ana-
lyzed are influenced by independent genetic factors. If rG = 1 then the genetic factors are completely shared21,22.
Sex, age, BMI, age2, sex by age and sex by age2 interactions were included as covariates in the analyses. 
P-values < 0.05 were considered statistically significant. Age2 was included to take potential non-linear effects of 
age on outcome phenotypes into account. All study procedures were performed in accordance with the relevant 
guidelines and regulations.
Results
A total of 1231 subjects with a median age of 28 years old (Interquartile Range, IQR: 21–45) were included in the 
final analysis. Slightly more women participated in the study (54.9%). Men were taller and heavier, but no signif-
icant sex differences were found for age and BMI. In general, men had significantly higher BP, HRV and BRS, but 
lower HR than women (Table 1).
Results of the univariate analyses showed that h2 of SBP and DBP vary among daytime, sleeping, total 24-hour, 
and office beat-to-beat measurements ranging from 16.8% to 40.4% (Table 2). HR and BRS showed a heritability 
of 31.9% and 20.6%, respectively, and HRV indices ranged from 11.1% to 20.5%. Heritability estimates of all the 
traits differed significantly from 0 (p < 0.01). Heritability estimation for BRS was similar (h2 = 19.2%) when only 
cases with complete data on both up-up and down-down BRS (n = 785) were considered.
The results of the bivariate quantitative genetic analyses showed consistently weak (r: −0.18 to 0.001) pheno-
typic correlations of HRV measurements (including SDNN, RMSSD, HF, LF, VLF and TP), with BP (Tables 3–4). 
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Characteristics
Men Women
p-valueN Statistica N Statistica
Anthropometric measurement
Age (years) 554 26.5 (20.0–42.0) 677 30.0 (22.0–45.0) NS
Height (cm) 554 166.0 (161–170.1) 677 152.0 (149.0–155.5) <0.01
Weight (kg) 554 67.0 (58.0–77.0) 677 56.0 (49.5–67.0) <0.01
Body mass index (kg/m2) 554 24.6 (20.9–28.2) 677 24.7 (21.2–28.6) NS
Ambulatory and office beat-to-beat BP
Daytime SBP (mmHg) 534 127.0 (121.0–135.0) 644 119.0 (111.0–128.0) <0.01
Daytime DBP (mmHg) 534 82.0 (76.8–89.0) 644 80.0 (74.0–88.0) <0.01
Sleep SBP (mmHg) 513 109.0 (102.0–118.5) 625 104.0 (95.0–114.5) <0.01
Sleep DBP (mmHg) 513 68.0 (61.0–75.0) 625 66.0 (59.0–73.0) <0.05
Total 24-hour SBP (mmHg) 523 124.0 (117.0–131.0) 632 116.0 (108.0–125.0) <0.01
Total 24-hour DBP (mmHg) 523 79.0 (74.0–86.0) 632 77.0 (71.3–84.0) <0.01
Office beat-to-beat SBP (mmHg) 507 116.4 (108.2–124.9) 616 105.1 (98.2–113.0) <0.01
Office beat-to-beat DBP (mmHg) 507 74.0 (68.0–82.1) 616 66.6 (60.4–73.0) <0.01
Heart rate (variability) and Baroreceptor reflex sensitivity
SDNN (ms) 523 64.4 (47.8–81.4) 624 51.0 (37.6–65.5) <0.01
RMSSD (ms) 523 39.5 (28.4–56.1) 624 33.9 (22.8–49.6) <0.01
lnHF (ms2) 498 10.8 (1.4) 610 10.4 (1.5) <0.01
lnLF (ms2) 500 4.2 (1.2) 610 3.4 (1.3) <0.01
lnVLF (ms2) 500 3.4 (1.1) 610 2.8 (1.2) <0.01
lnTP (ms2) 500 5.1 (1.1) 610 4.5 (1.2) <0.01
HR (beats/min) 526 66.9 (61.5–74.1) 629 72.6 (66.0–79.2) <0.01
lnBRS (ms/mmHg) 471 2.7 (0.6) 555 2.6 (0.7) <0.01
Table 1. Descriptive statistics stratified by sex. SDNN: standard deviation of normal-to-normal intervals; 
BP: blood pressure; SBP: systolic blood pressure; DBP: diastolic blood pressure; RMSSD: root mean square 
of successive differences; HF: high frequency; LF: low frequency; VLF: very low frequency; TP: total power; 
HR: heart rate; BRS: baroreceptor sensitivity; SDNN, RMSSD and HR were transformed by natural logarithm 
prior to testing for sex differences. NS: not significant. The daytime and sleep periods were determined for each 
subject according to their actual waking and sleeping time as recorded in their diaries. a:Data expressed as mean 
(sd) for normally distributed variable or median [IQR] in case of skewed distribution.
Traits N h2 SE p-value
Ambulatory and office beat-to-beat BP
Daytime SBP 1178 0.302 0.048 <0.01
Daytime DBP 1178 0.382 0.052 <0.01
Sleep SBP 1138 0.214 0.049 <0.01
Sleep DBP 1138 0.168 0.047 <0.01
Total 24-hour SBP 1155 0.321 0.051 <0.01
Total 24-hour DBP 1155 0.404 0.054 <0.01
Office beat-to-beat 
SBP 1123 0.244 0.053 <0.01
Office beat-to-beat 
DBP 1123 0.220 0.052 <0.01
Heart rate (variability) and Baroreceptor reflex sensitivity
lnSDNN 1147 0.123 0.048 <0.01
lnRMSSD 1147 0.205 0.059 <0.01
lnHF 1108 0.175 0.051 <0.01
lnLF 1110 0.137 0.045 <0.01
lnVLF 1110 0.111 0.039 <0.01
lnTP 1110 0.128 0.046 <0.01
lnHR 1155 0.319 0.060 <0.01
lnBRS 1026 0.206 0.058 <0.01
Table 2. Heritability estimates of BP, BRS, HRV and HR. *Models were adjusted for age, sex, BMI, age2, 
age × sex, and age2 × sex. *BP: blood pressure; SBP: systolic blood pressure; DBP: diastolic blood pressure; 
SDNN: standard deviation of normal-to-normal intervals; RMSSD: root mean square of successive differences; 
HF: high frequency; LF: low frequency; VLF: very low frequency; TP: total power; HR: heart rate; BRS: 
baroreceptor sensitivity. ln: indicates that data were ln-transformed prior analysis.
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Significant phenotypic correlations were found for SDNN and LF with sleeping ambulatory SBP and for all 
HRV measures except VLF with sleeping ambulatory DBP, for RMSSD with both 24-hour ambulatory SBP and 
DBP and for TP with 24-hour DBP only, for SDNN, RMSSD and HF with both office beat-to-beat SBP and DBP 
and for TP with office beat-to-beat SBP only. None of the genetic correlations contributed significantly to the 
phenotypic correlations between HRV and ambulatory/office beat-to-beat BP, but some significant environmen-
tal correlations were found, especially for the phenotypic correlations between HRV and office beat-to-beat BP.
HR had consistently positive, yet still weak phenotypic correlations with BP (r: 0.005 to 0.21). The correlation 
coefficients seemed higher with office beat-to-beat BP (Table 4) compared with ambulatory BP (Table 3) (SBP: 
0.20 vs. 0.005 to 0.04 and DBP: 0.21 vs. 0.02 to 0.07) and environmental factors always significantly contributed 
to the phenotypic correlation of HR with office beat-to-beat SBP and DBP (p < 0.01).
BRS showed consistently negative and similar phenotypic correlations with daytime ambulatory BP (r: −0.09 to 
−0.08; Table 3), sleeping ambulatory BP (r: −0.08 to −0.07; Table 3), 24-hour ambulatory BP (r: −0.10 to −0.08; 
Table 3) and office beat-to-beat BP (r: −0.13 to −0.10) (Table 4).
Discussion
The main purpose of our study was to estimate the heritability of BP and cardiac autonomic nervous system 
activity and explore whether shared genetic factors partly explained the inverse relationship. Our study echoed 
previous findings on the heritability estimates and small negative correlations between BP and indices of auto-
nomic nervous system activity. However, we did not identify significant genetic contributions to those phenotypic 
N



















lnSDNN 1223 0.09 (0.17) −0.10* (0.05) −0.06 0.72/0.28 0.04 (0.16) −0.08(0.05) −0.05 0.13/0.87
lnRMSSD 1223 0.02 (0.16) −0.09(0.05) −0.06 0.06/0.94 −0.03 (0.15) −0.07(0.05) −0.06 0.14/0.86
lnHF 1215 0.01 (0.16) −0.07(0.05) −0.05 0.04/0.96 −0.01 (0.15) −0.06(0.05) −0.04 0.06/0.94
lnLF 1215 0.08 (0.17) −0.06(0.05) −0.03 0.26/0.74 −0.07 (0.16) −0.01(0.05) −0.03 0.69/0.31
lnVLF 1215 0.15 (0.19) −0.03(0.05) 0.001 0.54/0.46 −0.03 (0.18) −0.01(0.05) −0.01 0.45/0.55
lnTP 1215 0.06 (0.18) −0.06(0.05) −0.04 0.20/0.80 −0.06 (0.17) −0.04(0.05) −0.05 0.31/0.69
lnHR 1223 −0.14 (0.13) 0.07(0.05) 0.005 0.48/0.52 0.03 (0.13) 0.02(0.06) 0.02 0.45/0.55
lnBRS 1211 −0.17(0.15) −0.06(0.05) −0.09§ 0.49/0.51 −0.11(0.15) −0.07(0.06) −0.08§ 0.43/0.57
N Ambulatory Sleep SBP Ambulatory Sleep DBP
lnSDNN 1214 −0.02 (0.19) −0.08(0.05) −0.06§ 0.05/0.95 −0.13 (0.21) −0.07(0.05) −0.10§ 0.27/0.73
lnRMSSD 1214 0.09 (0.19) −0.07(0.05) −0.04 0.25/0.75 −0.08 (0.21) −0.08* (0.05) −0.08§ 0.18/0.82
lnHF 1204 0.08(0.19) −0.07(0.05) −0.04 0.23/0.77 0.03 (0.20) −0.09(0.05) −0.07§ 0.07/0.93
lnLF 1205 0.05 (0.20) −0.09(0.05) −0.07§ 0.11/0.89 0.01 (0.22) −0.08 (0.05) −0.07§ 0.02/0.98
lnVLF 1205 0.15 (0.22) −0.04(0.05) −0.01 0.44/0.56 0.14 (0.24) −0.08(0.05) −0.05 0.22/0.78
lnTP 1205 0.10 (0.21) −0.09(0.05) −0.06 0.20/0.80 0.09 (0.23) −0.11* (0.05) −0.18§ 0.13/0.87
lnHR 1214 −0.05 (0.16) 0.07(0.05) 0.04 0.23/0.77 0.05 (0.17) 0.08(0.05) 0.07§ 0.17/0.83
lnBRS 1197 −0.19(0.18) −0.03(0.05) −0.07§ 0.67/0.33 −0.23(0.20) −0.04(0.05) −0.08§ 0.58/0.42
N Ambulatory 24-hour SBP Ambulatory 24-hour DBP
lnSDNN 1216 0.08 (0.17) −0.10(0.05) −0.06 0.19/0.81 0.01 (0.16) −0.08(0.05) −0.05 0.04/0.96
lnRMSSD 1216 0.02 (0.16) −0.10(0.05) −0.07§ 0.06/0.94 −0.04 (0.15) −0.09(0.05) −0.07§ 0.15/0.85
lnHF 1206 0.02 (0.16) −0.08(0.05) −0.06 0.07/0.93 −0.04 (0.15) −0.07(0.05) −0.06 0.18/0.82
lnLF 1207 0.09 (0.17) −0.08(0.05) −0.04 0.24/0.76 −0.07 (0.16) −0.04(0.05) −0.04 0.37/0.63
lnVLF 1207 0.15 (0.19) −0.05(0.05) −0.01 0.43/0.57 −0.02 (0.18) −0.03(0.05) −0.02 0.16/0.84
lnTP 1207 0.07 (0.18) −0.08(0.05) −0.05 0.19/0.81 −0.06 (0.17) −0.07(0.05) −0.06§ 0.22/0.78
lnHR 1216 −0.13 (0.13) 0.10(0.06) 0.02 0.38/0.62 0.02 (0.13) 0.06(0.06) 0.04 0.16/0.84
lnBRS 1201 −0.19(0.15) −0.06(0.05) −0.10§ 0.53/0.47 −0.14(0.15) −0.06(0.06) −0.08§ 0.50/0.50
Table 3. Bivariate quantitative genetic analyses of HRV, HR, and BRS with ambulatory daytime/sleep/24-hour 
SBP/DBP examining the genetic, environmental, and phenotypic correlations. Models were adjusted for age, 
sex, BMI, age2, age × sex, and age2 × sex. SBP: systolic blood pressure; DBP: diastolic blood pressure; rG: genetic 
correlation; rE: environmental correlation; rP: phenotypic correlation; SE: standard error; SDNN: standard 
deviation of normal-to-normal intervals; RMSSD: root mean square of successive differences; HF: high 
frequency; LF: low frequency; VLF: very low frequency; TP: total power; HR: heart rate; BRS: baroreceptor 
sensitivity. †Genetic correlations are significantly different from 0 (p < 0.05). *Environmental correlations are 
significantly different from 0 (p < 0.05). §Phenotypic correlations are significantly different from 0 (p < 0.05). 
A/E is the percentage of the phenotypic correlation that is caused by genes (A) or environment (E), based on the 
following equation: = × × + × ×r h r h e r e( ) ( )p BP G HRV BP E HRV
2 2 2 2 .
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correlations except for the correlations between HR and office beat-to-beat BP. Environment contributed more 
than genetic factors in our bivariate analyses, especially for the office beat-to-beat BP measurements.
Our study found moderate heritability for BP, which varied for different measurement conditions. It was 
higher for daytime or ambulatory BP measurements compared with sleeping or office beat-to-beat BP, respec-
tively. These results were in line with the univariate BP heritability estimates we published previously,15 and sim-
ilar to other family studies conducted in different populations (SBP: ranging from 0.30 to 0.37; DBP: ranging 
from 0.22 to 0.41)23–25. Some of this variation in BP heritability estimates may be due to different genes or sets of 
genes contributing to BP regulation in different measurement conditions such as office vs. real life or daytime vs. 
nighttime which was also shown in previous twin studies26,27. We also found differences in heritability estimates 
between HR and HRV indices, where HR (h2 = 0.32) had a higher heritability than all the HRV indices (h2 from 
0.11 to 0.21), which were somewhat smaller than estimates in the Kibbutzim family study28. The heritability of 
BRS in our study of 21% was very similar to the estimates reported by Riese et al. (22%)29.
We found consistently negative phenotypic correlations between HRV and BP and positive ones between HR 
and BP measures. This pattern of relationships was consistent with both cross-sectional3,4 and prospective cohort 
studies5,6. The latter longitudinal studies even showed that low HRV, high HR or reduced BRS preceded the onset 
of HTN indicating that they may cause new onset HTN. An alternative explanation of such findings might still be 
that genetic factors causing low HRV overlap with those conferring increased risk for HTN. However, even the 
phenotypic correlation coefficients we observed were relatively small compared with well-known risk factors of 
HTN such as obesity.
Our study identified a significant genetic contribution to the correlation between HR and office beat-to-beat 
DBP, but did not find significant genetic correlations of HRV/BRS indices with either ambulatory or office 
beat-to-beat BP. Also, significant environmental correlations were found for various HRV indices (including 
SDNN, RMSSD, HF and TP) and HR with office beat-to-beat SBP or DBP, but hardly any with ambulatory BP. 
One possible reason may be that the ECG from which HRV measures were derived and beat-to-beat BP were 
measured simultaneously in supine position, while ambulatory BP was measured during the previous day. Thus, 
correlations with ambulatory BP measures could have been expected to be smaller. Compared with ambulatory 
BP, office beat-to-beat BP measurements may be better suited to identify the shared genetic and/or environmental 
components with autonomic nervous system and some common genes may co-contribute to the synchronous 
regulation of HR and office beat-to-beat BP.
A strength of this family study is that it was conducted in a homogeneous Arab population, in which the indi-
viduals had a very similar genetic background (tradition of encouraging consanguineous marriage) and shared 
environmental effects (living in a relatively isolated region). Consequently it was expected to have better power to 
examine the genetic contributions to BP and HRV related traits than other studies conducted in outbred, hetero-
geneous populations13. Another strength is that BP values were measured using 24-hour ambulatory monitoring, 
which is believed to better predict target organ damage than conventional BP methods30. Furthermore many 
efforts were made to ensure data quality: (1) the effects of hypertension medication were corrected to optimally 
preserve genetic variability as recommended by previous studies16,17; (2) we combined up-up and down-down 
measures in a single BRS variable and conducted sensitivity analysis for BRS with and without missing data to 
optimally utilize the available data, and; (3) HRV measurements were all determined following the standards 
recommended by the Task Force of the European Society of Cardiology and the North American Society of 
Pacing and Electrophysiology7. However, there were also some limitations of this study. Firstly, although our study 
N



















lnSDNN 1155 0.06 (0.20) −0.10* (0.05) −0.07§ 0.12/0.88 −0.01 (0.20) −0.07(0.05) −0.06§ 0.03/0.97
lnRMSSD 1155 −0.01 (0.19) −0.14* (0.05) −0.12§ 0.02/0.98 −0.09 (0.20) −0.11* (0.05) −0.10§ 0.15/0.85
lnHF 1126 0.20 (0.20) −0.17* (0.05) −0.09§ 0.23/0.77 0.17 (0.20) −0.14* (0.05) −0.08§ 0.22/0.78
lnLF 1126 0.16 (0.20) −0.08(0.05) −0.03 0.31/0.69 0.22 (0.21) −0.07(0.05) −0.02 0.40/0.60
lnVLF 1126 0.22 (0.22) −0.08(0.05) −0.03 0.35/0.65 0.19 (0.22) −0.06(0.05) −0.02 0.36/0.64
lnTP 1126 0.22 (0.21) −0.12* (0.05) −0.06§ 0.28/0.72 0.22 (0.22) −0.10* (0.05) −0.05 0.30/0.70
lnHR 1155 0.29 (0.14) 0.17* (0.05) 0.20§ 0.40/0.60 0.39† (0.14) 0.14* (0.05) 0.21§ 0.50/0.50
lnBRS 1124 −0.22(0.18) −0.10 (0.05) −0.13§ 0.39/0.61 −0.17(0.19) −0.08 (0.05) −0.10§ 0.36/0.64
Table 4. Bivariate quantitative genetic analyses of HRV, HR and BRS with office beat-to-beat resting SBP/DBP 
examining the genetic, environmental, and phenotypic correlations. Models were adjusted for age, sex, BMI, 
age2, age × sex, and age2 × sex. SBP: systolic blood pressure; DBP: diastolic blood pressure; rG: genetic 
correlation; rE: environmental correlation; rP: phenotypic correlation; SE: standard error; SDNN: standard 
deviation of normal-to-normal intervals; RMSSD: root mean square of successive differences; HF: high 
frequency; LF: low frequency; VLF: very low frequency; TP: total power; HR: heart rate; BRS: baroreceptor 
sensitivity. †Genetic correlations are significantly different from 0 (p < 0.05). *Environmental correlations are 
significantly different from 0 (p < 0.05). §Phenotypic correlations are significantly different from 0 (p < 0.05). 
A/E is the percentage of the phenotypic correlation that is caused by genes (A) or environment (E), based on the 
following equation: r h r h e r e( ) ( )p BP G HRV BP E HRV
2 2 2 2= × × + × × .
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contained data on more than 1200 participants, the sample size may still not be large enough. The associations we 
are investigating were small and some of them were not significantly statistically correlated. So, underlying genetic 
contributions to these correlations may also be too small to detect with the current sample size. Interestingly, 
using results from meta-analyses of genome-wide association studies of both HRV indices and BP based on very 
large sample sizes31 we recently did find significant negative genetic correlations between HRV and BP ranging 
between −0.35 and −0.20. Secondly, our study was conducted using a cross-sectional design and only major con-
founding factors, i.e. age, age2, sex, BMI and age-sex and age2-sex interactions. Additional covariates, including 
but not limited to central adiposity measures such as waist-to-hip ratio may have slightly changed the results.
To conclude, our study in a homogeneous Arab population echoed prior findings on HRV, HR and BRS’ 
effects on BP regulation. But it also indicated that those correlations may be relatively weak compared with other 
well-known risk factors. In addition, the genetic effects contributing to those correlations were not as significant 
as expected and only observed under some specific conditions (e.g. HR and office beat-to-beat BP) which indi-
cated the complexity of underlying mechanisms explaining those correlations.
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